Systems and methods for reduction of oxygen tension in electrochemical biosensors

US11852604B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11852604-B2
Application numberUS-202016913704-A
CountryUS
Kind codeB2
Filing dateJun 26, 2020
Priority dateJun 26, 2019
Publication dateDec 26, 2023
Grant dateDec 26, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

In one embodiment, a system for detecting an analyte in a bodily fluid sample includes an electrochemical biosensor, the electrochemical biosensor configured to receive the bodily fluid sample, test for the analyte, and produce an analyte level for the analyte. The system further includes a mediator, the mediator configured to provide for the testing of the analyte by facilitating electron exchange between the analyte and the biosensor. The system further includes an oxygen tension reducing agent, the oxygen tension reducing agent reducing interference of oxygen with the operation of the mediator.

First claim

Opening claim text (preview).

What is claimed as new and desired to be protected by Letters Patent of the United States is: 1. A method of testing for an analyte, with reduced interference of oxygen, the method comprising: providing a system including: an electrochemical biosensor, the electrochemical biosensor configured to receive a bodily fluid sample, test for the analyte, and produce an analyte level for the analyte; a mediator, the mediator configured to provide for the testing of the analyte by facilitating electron exchange between the analyte and the biosensor, wherein the mediator is ferrocyanide and the analyte is hemoglobin; an oxygen tension reducing agent; a meter for receiving the electrochemical biosensor; dosing the electrochemical biosensor with a sample containing the analyte; reducing the interference of oxygen with the operation of the mediator with the oxygen tension reducing agent; detecting an electrical property of the sample with the meter and electrochemical biosensor; and, calculating an analyte level of the analyte with the meter, wherein the oxygen tension reducing agent is laccase. 2. The method of claim 1 , further comprising reducing the interference of oxygen with the oxygen tension reducing agent, wherein the oxygen reducing reagent is laccase. 3. A method of testing for an analyte, with reduced interference of oxygen, the method comprising: providing a system including: an electrochemical biosensor, the electrochemical biosensor configured to receive a bodily fluid sample, test for the analyte, and produce an analyte level for the analyte; a mediator, the mediator configured to provide for the testing of the analyte by facilitating electron exchange between the analyte and the biosensor, wherein the mediator is ferrocyanide and the analyte is hemoglobin; an oxygen tension reducing agent; a meter for receiving the electrochemical biosensor; dosing the electrochemical biosensor with a sample containing the analyte; reducing the interference of oxygen with the operation of the mediator with the oxygen tension reducing agent; detecting an electrical property of the sample with the meter and electrochemical biosensor; and, calculating an analyte level of the analyte with the meter, wherein the oxygen tension reducing agent is a platinum electrode. 4. The method of claim 3 , wherein the reducing includes activating the platinum electrode at oxygen reducing voltage, which causes the platinum electrode to reduce oxygen interference, and then activating the platinum electrode at a detection voltage.

Assignees

Inventors

Classifications

  • Test elements therefor, i.e. disposable laminated substrates with electrodes, reagent and channels (optical biosensors G01N33/52) · CPC title

  • Devices therefor, e.g. test element readers, circuitry (details not specific to biochemical electrodes G01N33/4875) · CPC title

  • Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration (coding of calibration information G01N33/48771) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11852604B2 cover?
In one embodiment, a system for detecting an analyte in a bodily fluid sample includes an electrochemical biosensor, the electrochemical biosensor configured to receive the bodily fluid sample, test for the analyte, and produce an analyte level for the analyte. The system further includes a mediator, the mediator configured to provide for the testing of the analyte by facilitating electron exch…
Who is the assignee on this patent?
Polymer Technology Systems Inc, Polymer Tech System Inc
What technology area does this patent fall under?
Primary CPC classification G01N27/3272. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).